Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Surasit Issarachai"'
Autor:
Metasebya Solomon, Gretchen Purcell Jackson, Yull E. Arriaga, Surasit Issarachai, Palita Lungchukiet, Rezzan Hekmat, Irene Dankwa-Mullan, Edward H. Shortliffe, Tanawat Jirakulaporn, Pattanawadee Wongrattananon, Nimit Taechakraichana, Wisanu Boonpakdee, Wimolrat Decha, Harit Suwanrusme, Suthida Suwanvecho, Vimla L. Patel, Anita M. Preininger, Narongsak Kiatikajornthada, Nittaya Thanakarn, Suwei Wang
Publikováno v:
Journal of the American Medical Informatics Association : JAMIA
Objective IBM(R) Watson for Oncology (WfO) is a clinical decision-support system (CDSS) that provides evidence-informed therapeutic options to cancer-treating clinicians. A panel of experienced oncologists compared CDSS treatment options to treatment
Autor:
Palita Lungchukiet, Edward H. Shortliffe, Irene Dankwa-Mullan, Tanawat Jirakulaporn, Surasit Issarachai, Wimolrat Decha, Jaime Esquivel, Wisanu Boonpakdee, Vimla L. Patel, Pattanawadee Wongrattananon, Yull Edwin Arriaga, Harit Suwanrusme, Metasebya Solomon, Anita M. Preininger, Nimit Taechakraichana, Gretchen Purcell Jackson, Nittaya Thanakarn, Narongsak Kiatikajornthada, Suwei Wang, Suthida Suwanvecho
Publikováno v:
Journal of Global Oncology. 5:95-95
95 Background: Watson for Oncology (WFO) is an artificial intelligence (AI) based clinical decision-support tool trained by Memorial Sloan Kettering. This retrospective observational study of breast, lung, colon and rectal cancer examined the concord
Autor:
Tanawat Jirakulaporn, Suthida Suwanvecho, Edward H. Shortliffe, Palita Lungchukiet, Wimolrat Decha, Jaime Esquivel, Nimit Taechakraichana, Anita M. Preininger, Sarah Kefayati, Vimla L. Patel, Gretchen Purcell Jackson, Pattanawadee Wongrattananon, Irene Dankwa-Mullan, Nittaya Thanakarn, Narongsak Kiatikajornthada, Harit Suwanrusme, Surasit Issarachai, Wisanu Boonpakdee
Publikováno v:
Journal of Clinical Oncology. 37:6553-6553
6553 Background: Clinical decision-support systems (CDSS) such as Watson for Oncology (WFO) may reduce treatment variation in oncology, provided options offered by the system are at least as acceptable as expert, evidence-based options. Deviation fro
Autor:
Ching-Kun Wang, Theera Umsawasdi, Narongsak Kiatikajornthada, Wimolrat Decha, Alexandra Urman, Suthida Suwanvecho, Surasit Issarachai, Irene Dankwa-Mullan, Harit Suwanrusme
Publikováno v:
Journal of Clinical Oncology. 36:e18584-e18584
e18584Background: IBM Watson for Oncology (WFO) is a clinical decision support software that uses natural language processing (NLP) to assist providers to make expeditious treatment decisions. This...
Publikováno v:
Blood. 88:3383-3390
FLT3 ligand is a hematopoietic growth factor that plays a key role in growth of primitive hematopoietic cells. FLT3 receptor mRNA is found in early hematopoietic progenitors and in human myeloid leukemia blasts. Much less is known about the surface e
Publikováno v:
Blood cells, moleculesdiseases. 29(1)
In this report we examined the kinetics of accumulation in muscle tissue of donor-derived CD45+ and CD45- cells from one to several weeks post-bone marrow transplantation. Only after hemopoiesis is fully reconstituted are CD45+ cells recovered from m
Publikováno v:
Experimental hematology. 30(4)
Objective The nature of cells residing in muscle giving rise to hemopoietic colonies in vitro or hemopoietic reconstitution in vivo has been unclear. The goal of the present study was to characterize these cells and uncover their potential site of or